Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
Vaccine|June 27, 2006
Modelling the health-economic impact of the next influenza pandemic in The NetherlandsE Hak, M J Meijboom, E BuskensEpidemiology and Infection|October 18, 2008
Effectiveness of influenza vaccination in the elderly in South AfricaA van Vuuren, P Rheeder, E HakPharmacopsychiatry|April 22, 2016
Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age PsychiatryE Berm, R Kok, E Hak, et al.Journal of Clinical Epidemiology|July 16, 2008
Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studiesR H H Groenwold, E Hak, A W HoesThe European Respiratory Journal|February 14, 2009
Impact of influenza vaccination on mortality risk among the elderlyR H H Groenwold, A W Hoes, E HakJournal of Clinical Epidemiology|October 27, 2004
A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysisE Hak, F Wei, D E Grobbee, et al.Current Medical Research and Opinion|September 12, 2015
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patientsF M de Vries, J Voorham, E Hak, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2020
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping reviewM P Oktora, K P Kerr, E Hak, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 14, 2014
Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 dataG Gefenaite, M J Bijlsma, H J Bos, et al.Vaccine|November 25, 2010
Effectiveness of the Q fever vaccine: a meta-analysisG Gefenaite, J M Munster, R van Houdt, et al.Pageof 11